Research findings: In conjunction with researchers at Roche and the National Taiwan University Hospital and College of Medicine in Taipei, the conclusions of the study demonstrated that LungFlag™ was able to work on Taiwanese EMR data and presented superiority over criteria based selection of individuals (USPSTF) and performed better than gold standard benchmark risk model PLCOm2012 that was adapted to be used on EMR data. The results were comparable to the previous validation studies and indicates that LungFlag™ can immediately support Taiwan screening program in identifying elevated risk populations among ever-smokers and potentially also on never-smokers populations.

OpiSafe is an award-winning solution provider of platforms designed to manage the opioid response for prescribers, dispensers, public health agencies, and patients and their families. Their approach helps close the gap between the epidemic and the solutions that stakeholders need to respond.

OpiSafe is an award winning software company with three innovative software systems---OpiSafe, OpiRescue, and TreatmentGPS---that can be deployed by state agencies and health care systems/providers to assure safe opioid prescribing, prevent and respond to opioid overdoses, and increase access to treatment for persons with opioid use disorder. The systems connect to, and create interoperable flows of, data between several important sources: state Prescription Drug Monitoring Programs (PDMPs/PMPs), toxicology laboratories, Health Information Exchanges (HIEs), direct patient-reported data, and others, and merge them into decision support engines and interfaces that are integrated into clinical workflow (EHRs) for use by clinicians to improve care for patients, into dashboards for use by state agencies or health systems for population health initiatives, or into smartphone apps for use by patients and families.

Assess a patient's holistic risk profile beyond the PDMP.